Cemiplimab in recurrent cervical cancer: Final analysis of overall survival in the phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial
Titel:
Cemiplimab in recurrent cervical cancer: Final analysis of overall survival in the phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial
Auteur:
Oaknin, Ana Monk, Bradley J. de Melo, Andreia Cristina Kim, Hee Seung Kim, Yong Man Lisyanskaya, Alla S. Samouëlian, Vanessa Lorusso, Domenica Damian, Fernanda Chang, Chih-Long Gotovkin, Evgeniy Takahashi, Shunji Ramone, Daniella Maćkowiak-Matejczyk, Beata Polastro, Laura Alia, Eva Maria Guerra Colombo, Nicoletta Makarova, Yulia Goh, Jeffrey C. Hasegawa, Kosei Mora, Paulo Pikiel, Joanna Srivastav, Ratnesh Rischin, Danny Rubio, Maria Jesús Perez, Javier Yoo, Suk Young Gao, Bo Jamil, Shaheda Seebach, Frank Lowy, Israel Mathias, Melissa Fury, Matthew G. Tewari, Krishnansu S.